GLIBENCLAMID LPH 3.5mg tablets medication leaflet

A10BB01 glibenclamide • Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Sulfonylureas

Glibenclamide is an antidiabetic medication from the sulfonylurea class, used to control blood sugar levels in patients with type 2 diabetes. It works by stimulating the pancreas to produce more insulin, thereby helping to lower blood sugar levels.

It is recommended as part of a treatment plan that includes a balanced diet, regular physical activity, and blood sugar monitoring. Glibenclamide is effective in reducing the risk of diabetes-related complications, such as damage to small blood vessels (retinopathy, nephropathy).

Side effects may include hypoglycemia (excessive drop in blood sugar), nausea, weight gain, dizziness, or allergic reactions. It is important for patients to follow the prescribed dosage and watch for signs of hypoglycemia, such as shaking, sweating, or confusion.

General data about GLIBENCLAMID LPH 3.5mg

Substance: glibenclamide

Date of last drug list: 01-07-2013

Commercial code: W41463003

Concentration: 3.5mg

Pharmaceutical form: tablets

Quantity: 2000

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Concentrations available for glibenclamide

1.75mg, 3.5mg, 5mg